Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardica receives 510(k) clearance for PAS-Port anastomosis system

This article was originally published in Clinica

Executive Summary

The US FDA has granted 510(k) clearance for the PAS-Port proximal anastomosis system for use in cardiac bypass surgery. The PAS-Port system, developed by Redwood City, California-based firm Cardica, connects a grafted vein with the aorta. The system allows an automated proximal anastomosis to be conducted without the need to clamp and manipulate the aorta, typically within one minute. Eliminating this clamp reduces the risk of release of small blood clots and other debris, thus reducing the chances of stroke and other neurological complications. The approval caused Cardica's share price to rise 25.8%, reaching $10.05; a second rise may be on the cards when the device is launched "in the next several weeks".

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043016

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel